Hancock Whitney Corp Gilead Sciences, Inc. Transaction History

Hancock Whitney Corp

$3.07 Billion
Q3 2024

A detailed history of Hancock Whitney Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Hancock Whitney Corp holds 50,172 shares of GILD stock, worth $4.69 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

50,172

Previous 44,484 12.79%

Holding current value

$4.69 Million

Previous $3.05 Million 37.78%

% of portfolio

0.14%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $378,763 - $477,735	5,688 Added 12.79%	50,172 $4.21 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $4.51 Million - $5.21 Million	-71,495 Reduced 61.64%	44,484 $3.05 Million
Q1 2024 May 16, 2024	BUY	$71.58 - $87.29 $433,059 - $528,104	6,050 Added 5.5%	115,979 $8.5 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $887,226 - $1.01 Million	12,109 Added 12.38%	109,929 $8.91 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $72,461 - $79,056	-980 Reduced 0.99%	97,820 $7.33 Million
Q2 2023 Nov 13, 2023	SELL	$76.01 - $86.7 $1.14 Million - $1.3 Million	-15,021 Reduced 13.2%	98,800 $7.61 Million
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $1.14 Million - $1.3 Million	-15,021 Reduced 13.2%	98,800 $7.62 Million
Q1 2023 Nov 13, 2023	SELL	$77.31 - $88.08 $2.23 Million - $2.54 Million	-28,846 Reduced 20.22%	113,821 $9.44 Million
Q1 2023 May 16, 2023	SELL	$77.31 - $88.08 $2.23 Million - $2.54 Million	-28,846 Reduced 20.22%	113,821 $9.44 Million
Q4 2022 Nov 13, 2023	BUY	$62.32 - $89.47 $2.73 Million - $3.92 Million	43,867 Added 44.4%	142,667 $12.2 Million
Q4 2022 Feb 03, 2023	SELL	$62.32 - $89.47 $97,780 - $140,378	-1,569 Reduced 1.09%	142,667 $12.2 Million
Q3 2022 Oct 26, 2022	SELL	$59.54 - $68.01 $238,636 - $272,584	-4,008 Reduced 2.7%	144,236 $8.9 Million
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $181,298 - $204,196	3,141 Added 2.16%	148,244 $9.16 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $147,348 - $184,643	2,544 Added 1.78%	145,103 $8.63 Million
Q4 2021 Jan 25, 2022	SELL	$64.88 - $73.64 $252,642 - $286,754	-3,894 Reduced 2.66%	142,559 $10.4 Million
Q3 2021 Nov 04, 2021	SELL	$67.69 - $73.03 $252,416 - $272,328	-3,729 Reduced 2.48%	146,453 $10.2 Million
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $4.9 Million - $5.35 Million	77,145 Added 105.62%	150,182 $10.3 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $116,520 - $132,949	-1,942 Reduced 2.59%	73,037 $4.72 Million
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $261,043 - $297,446	-4,608 Reduced 5.79%	74,979 $4.37 Million
Q3 2020 Nov 05, 2020	SELL	$62.1 - $78.08 $572,251 - $719,507	-9,215 Reduced 10.38%	79,587 $5.03 Million
Q2 2020 Jul 30, 2020	BUY	$72.34 - $84.0 $331,895 - $385,392	4,588 Added 5.45%	88,802 $6.83 Million
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $2.25 Million - $2.88 Million	35,878 Added 74.23%	84,214 $6.3 Million
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $12,693 - $13,962	206 Added 0.43%	48,336 $3.14 Million
Q3 2019 Oct 29, 2019	BUY	$62.51 - $69.0 $1.06 Million - $1.17 Million	17,017 Added 54.69%	48,130 $3.05 Million
Q2 2019 Aug 29, 2019	SELL	$61.87 - $69.38 $75,419 - $84,574	-1,219 Reduced 3.77%	31,113 $2.1 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $154,136 - $172,673	2,465 Added 8.25%	32,332 $2.1 Million
Q4 2018 Feb 15, 2019	BUY	$60.54 - $79.0 $177,866 - $232,102	2,938 Added 10.91%	29,867 $1.87 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $1.92 Million - $2.13 Million	26,929 New	26,929 $2.08 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Account

Hancock Whitney Corp Gilead Sciences, Inc. Transaction History